\-\ Texto\\:\\ \ \(0\)\
\-\ radiographically\\,\\ the\\ lungs\\ have\\ a\\ characteristic\\ pattern\\ consisting\\ of\\ fine\\ reticular\\ granularity\\ of\\ the\\ parenchyma\\ and\\ air\\ bronchograms\\ that\\ are\\ often\\ more\\ prominent\\ early\\ in\\ the\\ left\\ lower\\ lobe\\ because\\ of\\ superimposition\\ of\\ the\\ cardiac\\ shadow\\.\\ occasionally\\,\\ the\\ initial\\ cxr\\ is\\ normal\\ and\\ develops\\ into\\ the\\ typical\\ pattern\\ by\\ 6\\-12\\ hours\\ of\\ life\\.\\ there\\ can\\ be\\ considerable\ \(0\)\
\-\ ion\\ among\\ films\\ due\\ to\\ phase\\ of\\ respiration\\ and\\ use\\ of\\ cpap\\.\\ this\\ case\\ illustrates\\ how\\ medical\\ management\\ with\\ close\\ radiographic\\ follow\\ up\\ can\\ drastically\\ improve\\ the\\ hmd\\ related\\ morbidity\\ and\\ mortality\\.\ \(0\)\
\-\ hyaline\\ membrane\\ disease\ \(2\)\
\-\ patient\\ is\\ a\\ 1123\\ g\\ caucasian\\ infant\\ male\\ born\\ at\\ 29\\+0\\ weeks\\ gestation\\ via\\ low\\ transverse\\ c\\-section\\ due\\ to\\ maternal\\ pre\\-eclampsia\\ and\\ abnormal\\ non\\-reassuring\\ fetal\\ heart\\ tracings\\.\\ upon\\ delivery\\ the\\ patient\\ was\\ noted\\ to\\ have\\ respiratory\\ distress\\ with\\ grunting\\ and\\ retractions\\.\\ he\\ was\\ intubated\\,\\ given\\ one\\ dose\\ of\\ survanta\\,\\ and\\ started\\ on\\ a\\ rule\\-out\\ sepsis\\ protocol\\ with\\ cbc\\,\\ blood\\ cultures\\,\\ and\\ started\\ on\\ ampicillin\\ and\\ gentamycin\\.\\ the\\ patient\\'s\\ chest\\ x\\-ray\\ showed\\ ground\\ glass\\ opacity\\ consistent\\ with\\ hyaline\\ membrane\\ disease\\.\\ the\\ patient\\ did\\ not\\ improve\\ with\\ surfactant\\.\\ he\\ was\\ then\\ placed\\ on\\ a\\ high\\ frequency\\ oscillator\\ ventilator\\ with\\ slight\\ improvement\\.\\ the\\ patient\\ was\\ then\\ given\\ another\\ dose\\ of\\ surfactant\\ and\\ kept\\ on\\ the\\ oscillator\\.\\ over\\ the\\ next\\ several\\ hours\\ the\\ patient\\'s\\ lung\\ opacity\\ markedly\\ improved\\.\ \(0\)\
\-\ hyaline\\ membrane\\ disease\\ is\\ a\\ major\\ cause\\ of\\ death\\ in\\ the\\ newborn\\ period\\.\\ approximately\\ 50\\%\\ of\\ all\\ neonatal\\ deaths\\ are\\ due\\ to\\ hmd\\ or\\ its\\ complications\\.\\ the\\ lungs\\ are\\ poorly\\ compliant\\ due\\ to\\ a\\ deficiency\\ of\\ surfactant\\ which\\ results\\ in\\ progressive\\ atelectasis\\,\ \(0\)\
\-\ intra\\-pulmonary\\ shunting\\,\\ hypoxemia\\,\\ and\\ cyanosis\\.\\ the\\ hyaline\\ membrane\\ that\\ forms\\ and\\ lines\\ the\\ alveoli\\ is\\ composed\\ of\\ protein\\ and\\ sloughed\\ epithelium\\.\\ this\\ is\\ the\\ result\\ of\\ oxygen\\ exposure\\,\\ alveolar\\ capillary\\ leakage\\,\\ and\\ the\\ forces\\ generated\\ by\\ mechanical\\ ventilation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hyaline\\:\\ 0\\.07470909141118395\ \(0\)\
\-\ surfactant\\:\\ 0\\.06179887047969415\ \(0\)\
\-\ membrane\\:\\ 0\\.061270408980993014\ \(0\)\
\-\ hmd\\:\\ 0\\.04967811158046821\ \(0\)\
\-\ oscillator\\:\\ 0\\.04967811158046821\ \(0\)\
\-\ due\\:\\ 0\\.027893298507068374\ \(0\)\
\-\ improve\\:\\ 0\\.02784610732064332\ \(0\)\
\-\ dose\\:\\ 0\\.027349926618426997\ \(0\)\
\-\ granularity\\:\\ 0\\.02695877193873547\ \(0\)\
\-\ ion\\:\\ 0\\.02695877193873547\ \(0\)\
\-\ 1123\\:\\ 0\\.02695877193873547\ \(0\)\
\-\ 29\\+0\\:\\ 0\\.02695877193873547\ \(0\)\
\-\ tracings\\:\\ 0\\.02695877193873547\ \(0\)\
\-\ survanta\\:\\ 0\\.02695877193873547\ \(0\)\
\-\ intra\\-pulmonary\\:\\ 0\\.02695877193873547\ \(0\)\
\-\ drastically\\:\\ 0\\.024839055790234106\ \(0\)\
\-\ non\\-reassuring\\:\\ 0\\.024839055790234106\ \(0\)\
\-\ gentamycin\\:\\ 0\\.024839055790234106\ \(0\)\
\-\ opacity\\:\\ 0\\.02443569943951964\ \(0\)\
\-\ hypoxemia\\:\\ 0\\.02359910133118773\ \(0\)\
\-\ started\\:\\ 0\\.023312367694318284\ \(0\)\
\-\ compliant\\:\\ 0\\.022719339641732745\ \(0\)\
\-\ sloughed\\:\\ 0\\.022719339641732745\ \(0\)\
\-\ superimposition\\:\\ 0\\.022036943460343725\ \(0\)\
\-\ pre\\-eclampsia\\:\\ 0\\.022036943460343725\ \(0\)\
\-\ ampicillin\\:\\ 0\\.02147938518268637\ \(0\)\
\-\ deaths\\:\\ 0\\.02147938518268637\ \(0\)\
\-\ 6\\-12\\:\\ 0\\.021007976375875183\ \(0\)\
\-\ rule\\-out\\:\\ 0\\.021007976375875183\ \(0\)\
\-\ grunting\\:\\ 0\\.020599623493231384\ \(0\)\
\-\ alveoli\\:\\ 0\\.020599623493231384\ \(0\)\
\-\ generated\\:\\ 0\\.020599623493231384\ \(0\)\
\-\ hours\\:\\ 0\\.020551665496078265\ \(0\)\
\-\ respiration\\:\\ 0\\.020239430723639994\ \(0\)\
\-\ pattern\\:\\ 0\\.01997824060594054\ \(0\)\
\-\ cpap\\:\\ 0\\.019917227311842364\ \(0\)\
\-\ lungs\\:\\ 0\\.0197907559509497\ \(0\)\
\-\ then\\:\\ 0\\.018599185800746727\ \(0\)\
\-\ ventilator\\:\\ 0\\.01847990734473002\ \(0\)\
\-\ kept\\:\\ 0\\.018294510947737867\ \(0\)\
\-\ leakage\\:\\ 0\\.018294510947737867\ \(0\)\
\-\ bronchograms\\:\\ 0\\.018119714575138637\ \(0\)\
\-\ given\\:\\ 0\\.017916907599488333\ \(0\)\
\-\ considerable\\:\\ 0\\.017797511163341\ \(0\)\
\-\ retractions\\:\\ 0\\.017648305768327446\ \(0\)\
\-\ forces\\:\\ 0\\.017239952885683647\ \(0\)\
\-\ epithelium\\:\\ 0\\.01711511498195198\ \(0\)\
\-\ reticular\\:\\ 0\\.016995173963134606\ \(0\)\
\-\ c\\-section\\:\\ 0\\.016661231174250838\ \(0\)\
\-\ shunting\\:\\ 0\\.016661231174250838\ \(0\)\
\-\ consisting\\:\\ 0\\.016457282016762543\ \(0\)\
\-\ maternal\\:\\ 0\\.016457282016762543\ \(0\)\
\-\ sepsis\\:\\ 0\\.016086147897483437\ \(0\)\
\-\ composed\\:\\ 0\\.015999998426637272\ \(0\)\
\-\ morbidity\\:\\ 0\\.015916209514747013\ \(0\)\
\-\ ventilation\\:\\ 0\\.015916209514747013\ \(0\)\
\-\ develops\\:\\ 0\\.015834655242324504\ \(0\)\
\-\ illustrates\\:\\ 0\\.015834655242324504\ \(0\)\
\-\ patient\\:\\ 0\\.015717283136080513\ \(0\)\
\-\ neonatal\\:\\ 0\\.015677795014839638\ \(0\)\
\-\ alveolar\\:\\ 0\\.015602282438110675\ \(0\)\
\-\ among\\:\\ 0\\.015528589619826083\ \(0\)\
\-\ intubated\\:\\ 0\\.015528589619826083\ \(0\)\
\-\ how\\:\\ 0\\.01545663091214965\ \(0\)\
\-\ g\\:\\ 0\\.01545663091214965\ \(0\)\
\-\ capillary\\:\\ 0\\.01538632657507106\ \(0\)\
\-\ cyanosis\\:\\ 0\\.015317602245248254\ \(0\)\
\-\ forms\\:\\ 0\\.015184620251548746\ \(0\)\
\-\ glass\\:\\ 0\\.015120236737182286\ \(0\)\
\-\ fine\\:\\ 0\\.015057180813014897\ \(0\)\
\-\ oxygen\\:\\ 0\\.014995398833450618\ \(0\)\
\-\ shadow\\:\\ 0\\.014875457814633243\ \(0\)\
\-\ he\\:\\ 0\\.014582185578183606\ \(0\)\
\-\ radiographically\\:\\ 0\\.014437840555793266\ \(0\)\
\-\ mechanical\\:\\ 0\\.014437840555793266\ \(0\)\
\-\ ground\\:\\ 0\\.014387292231783446\ \(0\)\
\-\ lines\\:\\ 0\\.014387292231783446\ \(0\)\
\-\ gestation\\:\\ 0\\.014288635160779712\ \(0\)\
\-\ mortality\\:\\ 0\\.014240475047727297\ \(0\)\
\-\ newborn\\:\\ 0\\.014240475047727297\ \(0\)\
\-\ death\\:\\ 0\\.014100384723472578\ \(0\)\
\-\ deficiency\\:\\ 0\\.014100384723472578\ \(0\)\
\-\ protocol\\:\\ 0\\.014055078650735141\ \(0\)\
\-\ frequency\\:\\ 0\\.013796493366245652\ \(0\)\
\-\ occasionally\\:\\ 0\\.013755444374404246\ \(0\)\
\-\ born\\:\\ 0\\.013635503355586871\ \(0\)\
\-\ exposure\\:\\ 0\\.013596546090212467\ \(0\)\
\-\ cultures\\:\\ 0\\.013445497908776452\ \(0\)\
\-\ delivery\\:\\ 0\\.013408873471324722\ \(0\)\
\-\ protein\\:\\ 0\\.013408873471324722\ \(0\)\
\-\ fetal\\:\\ 0\\.013301560566703103\ \(0\)\
\-\ next\\:\\ 0\\.0132666104265697\ \(0\)\
\-\ disease\\:\\ 0\\.012814105882712883\ \(0\)\
\-\ close\\:\\ 0\\.012755741666131883\ \(0\)\
\-\ poorly\\:\\ 0\\.012755741666131883\ \(0\)\
\-\ atelectasis\\:\\ 0\\.01255653890719928\ \(0\)\
\-\ caucasian\\:\\ 0\\.012474984634776767\ \(0\)\
\-\ improved\\:\\ 0\\.012448276133343266\ \(0\)\
\-\ infant\\:\\ 0\\.012369522322632517\ \(0\)\
\-\ markedly\\:\\ 0\\.012369522322632517\ \(0\)\
\-\ phase\\:\\ 0\\.0122927458054121\ \(0\)\
\-\ slight\\:\\ 0\\.0122927458054121\ \(0\)\
\-\ major\\:\\ 0\\.01221784971975982\ \(0\)\
\-\ period\\:\\ 0\\.01221784971975982\ \(0\)\
\-\ improvement\\:\\ 0\\.012193286503560236\ \(0\)\
\-\ was\\:\\ 0\\.012089021678454884\ \(0\)\
\-\ can\\:\\ 0\\.011854570963113575\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.011781877044974284\ \(0\)\
\-\ cbc\\:\\ 0\\.01167677721774429\ \(0\)\
\-\ \\'s\\:\\ 0\\.0115232209074437\ \(0\)\
\-\ life\\:\\ 0\\.011400373360043162\ \(0\)\
\-\ have\\:\\ 0\\.01131766408785989\ \(0\)\
\-\ another\\:\\ 0\\.011235030175730392\ \(0\)\
\-\ via\\:\\ 0\\.011217198615146928\ \(0\)\
\-\ parenchyma\\:\\ 0\\.011129567863586144\ \(0\)\
\-\ characteristic\\:\\ 0\\.011061227500613679\ \(0\)\
\-\ cxr\\:\\ 0\\.011027621624235711\ \(0\)\
\-\ distress\\:\\ 0\\.011010956166230925\ \(0\)\
\-\ respiratory\\:\\ 0\\.010849113959948533\ \(0\)\
\-\ films\\:\\ 0\\.01078670150847695\ \(0\)\
\-\ related\\:\\ 0\\.01078670150847695\ \(0\)\
\-\ prominent\\:\\ 0\\.01072553739010793\ \(0\)\
\-\ are\\:\\ 0\\.010686916261739466\ \(0\)\
\-\ upon\\:\\ 0\\.010680453959718929\ \(0\)\
\-\ placed\\:\\ 0\\.01057777415686387\ \(0\)\
\-\ results\\:\\ 0\\.010549059354570785\ \(0\)\
\-\ typical\\:\\ 0\\.010478430257339442\ \(0\)\
\-\ transverse\\:\\ 0\\.010478430257339442\ \(0\)\
\-\ complications\\:\\ 0\\.010355268486275404\ \(0\)\
\-\ use\\:\\ 0\\.010328559984841905\ \(0\)\
\-\ progressive\\:\\ 0\\.010328559984841905\ \(0\)\
\-\ result\\:\\ 0\\.010025028002898966\ \(0\)\
\-\ cardiac\\:\\ 0\\.0099536293362415\ \(0\)\
\-\ 50\\:\\ 0\\.009941889959155365\ \(0\)\
\-\ radiographic\\:\\ 0\\.009918545540638328\ \(0\)\
\-\ management\\:\\ 0\\.009860952426469852\ \(0\)\
\-\ its\\:\\ 0\\.009860952426469852\ \(0\)\
\-\ early\\:\\ 0\\.00955706106924293\ \(0\)\
\-\ did\\:\\ 0\\.009435531012210776\ \(0\)\
\-\ because\\:\\ 0\\.009142257848886996\ \(0\)\
\-\ \\,\\:\\ 0\\.009106454803333825\ \(0\)\
\-\ heart\\:\\ 0\\.009079754278008483\ \(0\)\
\-\ that\\:\\ 0\\.009027405067638064\ \(0\)\
\-\ on\\:\\ 0\\.008854935931075572\ \(0\)\
\-\ air\\:\\ 0\\.00884178173257482\ \(0\)\
\-\ cause\\:\\ 0\\.00884178173257482\ \(0\)\
\-\ by\\:\\ 0\\.008702574331772935\ \(0\)\
\-\ initial\\:\\ 0\\.008659272609416844\ \(0\)\
\-\ is\\:\\ 0\\.008597718323925469\ \(0\)\
\-\ showed\\:\\ 0\\.008568205712304882\ \(0\)\
\-\ the\\:\\ 0\\.008455613743341027\ \(0\)\
\-\ several\\:\\ 0\\.008400895522086812\ \(0\)\
\-\ often\\:\\ 0\\.008337839597919425\ \(0\)\
\-\ follow\\:\\ 0\\.00830336229953038\ \(0\)\
\-\ approximately\\:\\ 0\\.008085069805980376\ \(0\)\
\-\ medical\\:\\ 0\\.008040702752495426\ \(0\)\
\-\ and\\:\\ 0\\.007706807584865622\ \(0\)\
\-\ lung\\:\\ 0\\.007569293945684239\ \(0\)\
\-\ abnormal\\:\\ 0\\.00745288146885294\ \(0\)\
\-\ weeks\\:\\ 0\\.007416751550156417\ \(0\)\
\-\ all\\:\\ 0\\.007391203331594162\ \(0\)\
\-\ a\\:\\ 0\\.007277060583827546\ \(0\)\
\-\ low\\:\\ 0\\.007266568969010396\ \(0\)\
\-\ high\\:\\ 0\\.007151517006351118\ \(0\)\
\-\ blood\\:\\ 0\\.007132755573422934\ \(0\)\
\-\ one\\:\\ 0\\.007081747349573835\ \(0\)\
\-\ lobe\\:\\ 0\\.007031575987533743\ \(0\)\
\-\ up\\:\\ 0\\.0070270555078110804\ \(0\)\
\-\ over\\:\\ 0\\.00665334125425065\ \(0\)\
\-\ more\\:\\ 0\\.006535707367927114\ \(0\)\
\-\ to\\:\\ 0\\.006530093401268903\ \(0\)\
\-\ consistent\\:\\ 0\\.006407639965844658\ \(0\)\
\-\ chest\\:\\ 0\\.006252993883967947\ \(0\)\
\-\ into\\:\\ 0\\.006218123449418064\ \(0\)\
\-\ noted\\:\\ 0\\.006193948588540042\ \(0\)\
\-\ \\%\\:\\ 0\\.006095782976593296\ \(0\)\
\-\ this\\:\\ 0\\.005878515066141486\ \(0\)\
\-\ lower\\:\\ 0\\.005877254034751873\ \(0\)\
\-\ case\\:\\ 0\\.0057171389384320205\ \(0\)\
\-\ of\\:\\ 0\\.004987930309394\ \(0\)\
\-\ which\\:\\ 0\\.004878118003799843\ \(0\)\
\-\ male\\:\\ 0\\.00472539919843264\ \(0\)\
\-\ normal\\:\\ 0\\.004096674173085936\ \(0\)\
\-\ be\\:\\ 0\\.0040298370744462665\ \(0\)\
\-\ there\\:\\ 0\\.0038890383989755007\ \(0\)\
\-\ in\\:\\ 0\\.0038660296343142656\ \(0\)\
\-\ not\\:\\ 0\\.0037762038891190684\ \(0\)\
\-\ at\\:\\ 0\\.0035405601004025473\ \(0\)\
\-\ or\\:\\ 0\\.0030627607001948243\ \(0\)\
\-\ left\\:\\ 0\\.002923869324993623\ \(0\)\
\-\ with\\:\\ 0\\.0021468656163282523\ \(0\)\
\-\ \\.\\:\\ 0\\.0018455416319721305\ \(0\)\
